Table 3.
The Correlation NAFLD by Univariate Analysis
| Variables | Correlation Coefficient | P |
|---|---|---|
| Age | −0.115 | < 0.001 |
| Diabetes duration | −0.165 | < 0.001 |
| Sex | −0.043 | 0.150 |
| Smoking | 0.064 | 0.035 |
| BMI | 0.394 | < 0.001 |
| SBP | 0.096 | 0.001 |
| DBP | 0.190 | < 0.001 |
| TC | 0.122 | < 0.001 |
| LDL-c | 0.106 | < 0.001 |
| TG | 0.346 | < 0.001 |
| HDL-c | −0.222 | < 0.001 |
| HbA1c | 0.073 | 0.016 |
| AST | 0.040 | 0.188 |
| ALT | 0.184 | < 0.001 |
| GGT | 0.353 | < 0.001 |
| UA | 0.213 | < 0.001 |
| Scr | −0.008 | 0.790 |
| FPG | 0.148 | < 0.001 |
| FINS | 0.115 | 0.004 |
| HOMA-IR | 1.171 | < 0.001 |
| VFA | 0.385 | < 0.001 |
| SFA | 0.383 | < 0.001 |
| TG/HDL-c ratio | 0.354 | < 0.001 |
| METS-IR | 0.441 | < 0.001 |
Notes: Data were presented as mean ± SD for normally distributed variables, and median (interquartile ranges) for abnormal distributions. Independent-Samples T test and Mann–Whitney U-test were used for comparisons of normally and abnormally distributed continuous variables NAFLD groups, respectively. Correlation coefficients NAFLD and different variables were determined by Spearman correlation analysis, respectively.
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; HbA1c, glycated hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ- Glutamyl transpeptidase; UA, uric acid; Scr, serum creatinine; FPG, fasting plasma glucose; FINS, fasting insulin; HOMA-IR, homeostatic model assessment for insulin resistance; TyG, triglyceride glucose index; VFA, visceral fat area; SFA, subcutaneous fat area; METS-IR, metabolic score for IR; NAFLD, non-alcoholic fatty liver disease.